Biotechnology News

August 21, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--Learn about the Effective Use, Analysis, and Best Practices for Collecting eCOA Data in Oncology Programs in a new PHT Corporation educational webinar, September 10, 10-11am and 2-3pm EST.

August 21, 2014

MADISON, Wis.--(BUSINESS WIRE)--The 25th International Symposium on Human Identification (ISHI) 2014 will be held September 29–October 2 at the Arizona Biltmore, 2400 East Missouri Avenue, Phoenix, Arizona.

August 21, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth Provides Unprecedented Reimbursement Support with RxAssistance

August 21, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that nine posters and one oral presentation on data related to the Company’s next-generation antibiotics portfolio – including its lead candidate...

August 21, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII treatment for hemophilia A based on ADVATE.

August 21, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) announced that Celgene management will provide an overview of the Company at two upcoming investor conferences in the month of September. The conferences will be webcast live and a...

August 21, 2014

NEW YORK--(BUSINESS WIRE)--Angiocrine Bioscience, Inc. announced today that it has licensed the rights to a new technology developed by a team of researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College. The team was led by...

August 21, 2014

ATLANTA--(BUSINESS WIRE)--IPG, the Leader in Device Benefit Management, Recognized by Inc. 500|5000 for a Fourth Consecutive Year. Company Ranks No. 3299 Overall and No. 127 in Georgia on the 33rd Annual Inc. 500|5000 List.

August 21, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced that the company has initiated a multi-center, open-label expanded access program (EAP) in the United States for the investigational CDK 4/6 inhibitor, palbociclib. Through the program,...

August 21, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, released a site-level reference booklet that concentrates on EN ISO 14155:2011.

August 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) announced today that Tom Ulich, MD, InVivo’s Chief Scientific Officer, will present at the 4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa to be...

August 21, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Reacquires Baize’s Financial Interest in Pipeline Product Candidates. Baize to be issued 1,600,000 Compugen ordinary shares and is entitled to reduced revenue sharing until December 31, 2015

August 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced the appointment of Adriana (Andi) Karaboutis as executive vice president, Technology and Business Solutions, effective September 24, 2014. She will report directly to...

August 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert will present an overview at the 2014 Robert W. Baird conference.

August 21, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--The U.S. FDA has approved changes to the manufacturing process for the polytetrafluoroethylene (PTFE) coating on the delivery wire of Covidien's Pipeline™ embolization device.

August 21, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx received Notice of Allowance from the US Patent & Trademark Office for patent claiming the use of BL-7010 in preventing/decreasing gluten’s deleterious effects on gastrointestinal mucosa

August 21, 2014

SANTA ROSA, Calif.--(BUSINESS WIRE)--Direct Flow Medical®, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, today announced it has received the CE Mark (Conformité Européenne) for a 23mm sized valve as part of...

August 21, 2014

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: (STO:MVIR-B) Financial summary for the second quarter -- Net turnover totalled SEK 564.0 million (SEK 40.7 m), of which SEK 500.7 million was contributed by royalties for simeprevir. Revenues...

August 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing (NGS)-based oncology test system. The system...

August 20, 2014

LOS ANGELES--(BUSINESS WIRE)--Researchers at Children’s Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that can be used...

August 20, 2014

SÃO PAULO--(BUSINESS WIRE)--Covidien today officially opened its Covidien Center of Innovation Brazil (CCI Brazil), further expanding its educational and research capabilities in a key emerging market.

August 20, 2014

--(BUSINESS WIRE)--Hundreds of Health Care Professionals in Field of Spinal Cord Injury, Multiple Sclerosis and ALS to Gather in Las Vegas for Paralyzed Veterans of America’s 4th Annual Health Summit + EXPO

August 20, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PerfectServe announced the opening of a new office located in Atlanta, Georgia.

August 20, 2014

WASHINGTON--(BUSINESS WIRE)--The Licensing Executives Society (USA & Canada) Board of Trustees is launching LES 2020, an initiative aimed at enhancing the society's role as the premier association for innovation deal makers.

August 20, 2014

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Sullivan & Associates, an award-winning strategic healthcare communications agency, marks its 15-year anniversary this month—celebrating the clients and employees who have contributed to its success...

August 20, 2014

NASHVILLE, Tenn.--(BUSINESS WIRE)--NuSirt Biopharma is initiating a clinical trial to determine how the company’s patented technology may enhance the ability of a common Type 2 diabetes medication, metformin, to control blood sugar.

August 20, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced that Frost & Sullivan, a global growth consulting firm, has honored the Company with the Growth Excellence Leadership...

August 20, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen (Euronext:IPN; ADR:IPSEY) today announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A., responsible for all commercial and medical affairs operations throughout the region. She...

August 20, 2014

SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinical™, a full-service, Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, today announced the continued expansion of its corporate headquarters, marking its third expansion...

August 20, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014 in the pharma and biotech sectors. Meanwhile, skies appear brighter for the medtech sector...

August 20, 2014

LOS ANGELES--(BUSINESS WIRE)--Bud Genius (OTC:RIGH) has become more than a cannabis laboratory, launching new product distribution services for medical marijuana accessories in the growing number of states where legal.

August 20, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 18, in London.

August 20, 2014

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist received a Class 2 medical device license from Health Canada for its PROTEK Duo cannula for veno-venous extracorporeal life support (VV ECLS).

August 20, 2014

NEW YORK & SUMMIT, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement to Evaluate Immunotherapy and Chemotherapy Combination Regimen

August 20, 2014

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline’s (GSK) rights to Treximet® (...

August 20, 2014

SURREY, Canada--(BUSINESS WIRE)--QImaging™ launched a new, all-in-one camera package that supports demanding live cell fluorescence imaging requirements by combining the company's Rolera™ Thunder EMCCD and optiMOS™ sCMOS cameras

August 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the...

August 20, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--The AcroMetrix Oncology Hotspot Control provides a quality control material that can be used in laboratories with different NGS instrument platforms, assays and bioinformatics pipelines.

August 20, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare Life Sciences announced today that it will open a new 160,000 square-foot facility in Marlborough, Massachusetts, as the new headquarters for its US operations. A $21M investment in the long-term...

August 20, 2014

PRINCETON, N.J. and NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that they will present 14 abstracts (oral and poster presentations) at the ESC Congress 2014, organized by the...

August 20, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 in New York City at the Grand Hyatt Hotel.

August 20, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Pharma Start improves audit readiness with paperless eTMF solution from Veeva Systems.

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive’s research wins award at international research symposium Second Quarter (1 Apr. 2014 – 30 Jun. 2014) -- Net revenues were SEK 0 (5,335,000) and other operating income was SEK 1,128,...

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: CEO’s comments: "We have achieved strong profitability for the first half of the year with an operating margin of 29 % excluding license revenue from Nestlé. Including license revenue from...

August 20, 2014

NOTTINGHAM, England--(BUSINESS WIRE)--Source BioScience plc (LSE:SBS) the international laboratory services and products business publishes its Half Year Report for the six months ended 30 June 2014. Financial highlights Revenue increased by 46%...